ArticleHaematologica2023
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
Amandine Decroos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleHaematologica2023
Amandine Decroos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.